Tuesday, June 18, 2024

🌎 CRH Initiated, Repligen Initiated, RB Global Initiated and more...

Ratings changes for NVIDIA, Vanda Pharmaceuticals, Automatic Data Processing, PayPal, Intel, REGENXBIO, Zentalis Pharmaceuticals and more...Text "MarketBeat" to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.
June 18th, 2024
S and P pricesDow pricesQQQ prices
Follow MarketBeat on Twitter Join the MarketBeat Facebook Group Subscribe on YouTube 


Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)

Analysts' Upgrades
  • Juniper Networks (NYSE:JNPR) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating. They now have a $40.00 price target on the stock. This represents a 12.6% upside from the current price of $35.51.
  • Kroger (NYSE:KR) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $60.00 price target on the stock, up previously from $58.00. This represents a 15.4% upside from the current price of $51.98.
  • QuinStreet (NASDAQ:QNST) was upgraded by analysts at Craig Hallum from a "hold" rating to a "buy" rating. They now have a $22.00 price target on the stock. This represents a 31.3% upside from the current price of $16.76.
  • STMicroelectronics (NYSE:STM) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "sell" rating to a "neutral" rating. They now have a $45.80 price target on the stock, up previously from $35.50. This represents a 6.2% upside from the current price of $43.12.
  • Sunoco (NYSE:SUN) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $65.00 price target on the stock. This represents a 18.1% upside from the current price of $55.02.
  • View today's most recent analysts' upgrades at MarketBeat.com right arrow


Analysts' Downgrades
  • Aerovate Therapeutics (NASDAQ:AVTE) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $2.00 price target on the stock, down previously from $35.00. This represents a 33.8% upside from the current price of $1.50.
  • Aerovate Therapeutics (NASDAQ:AVTE) was downgraded by analysts at TD Cowen from a "buy" rating to a "hold" rating.The current price is $1.50.
  • Aerovate Therapeutics (NASDAQ:AVTE) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "inline" rating. They now have a $2.00 price target on the stock, down previously from $27.00. This represents a 33.8% upside from the current price of $1.50.
  • Equitable (NYSE:EQH) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. They now have a $43.00 price target on the stock, up previously from $40.00. This represents a 7.6% upside from the current price of $39.95.
  • First Solar (NASDAQ:FSLR) was downgraded by analysts at Janney Montgomery Scott from a "buy" rating to a "neutral" rating.The current price is $261.25.
  • Ovid Therapeutics (NASDAQ:OVID) was downgraded by analysts at Oppenheimer Holdings Inc. from an "outperform" rating to a "market perform" rating.The current price is $0.85.
  • Zentalis Pharmaceuticals (NASDAQ:ZNTL) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating.The current price is $5.68.
  • Zentalis Pharmaceuticals (NASDAQ:ZNTL) was downgraded by analysts at Wedbush from a "neutral" rating to an "underperform" rating. They now have a $4.00 price target on the stock, down previously from $15.00. This represents a 29.6% downside from the current price of $5.68.
  • View today's most recent analysts' downgrades at MarketBeat.com right arrow


Analysts' New Coverage
  • Autoliv (NYSE:ALV) is now covered by analysts at BNP Paribas. They set a "neutral" rating on the stock.The current price is $109.49.
  • Amerant Bancorp (NASDAQ:AMTB) is now covered by analysts at Janney Montgomery Scott. They set a "buy" rating and a $25.00 price target on the stock. This represents a 16.8% upside from the current price of $21.41.
  • Cardlytics (NASDAQ:CDLX) is now covered by analysts at Northland Securities. They set an "outperform" rating and a $14.00 price target on the stock. This represents a 71.8% upside from the current price of $8.15.
  • Celldex Therapeutics (NASDAQ:CLDX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $58.00 price target on the stock. This represents a 64.7% upside from the current price of $35.22.
  • CRH (NYSE:CRH) is now covered by analysts at Stephens. They set an "overweight" rating and a $95.00 price target on the stock. This represents a 22.1% upside from the current price of $77.83.
  • Innoviva (NASDAQ:INVA) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.The current price is $16.38.
  • Knife River (NYSE:KNF) is now covered by analysts at Stephens. They set an "overweight" rating and a $85.00 price target on the stock. This represents a 20.7% upside from the current price of $70.41.
  • Kopin (NASDAQ:KOPN) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $2.50 price target on the stock. This represents a 241.3% upside from the current price of $0.73.
  • Omega Therapeutics (NASDAQ:OMGA) is now covered by analysts at Raymond James. They set an "outperform" rating and a $12.00 price target on the stock. This represents a 474.2% upside from the current price of $2.09.
  • Pilgrim's Pride (NASDAQ:PPC) is now covered by analysts at Argus. They set a "buy" rating and a $41.00 price target on the stock. This represents a 17.0% upside from the current price of $35.03.
  • Praxis Precision Medicines (NASDAQ:PRAX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $155.00 price target on the stock. This represents a 296.2% upside from the current price of $39.12.
  • RB Global (NYSE:RBA) (TSE:RBA) is now covered by analysts at CIBC. They set a "sector outperform" rating on the stock.The current price is $81.25.
  • Repligen (NASDAQ:RGEN) is now covered by analysts at Guggenheim. They set a "neutral" rating on the stock.The current price is $122.60.
  • Sportradar Group (NASDAQ:SRAD) is now covered by analysts at JPMorgan Chase & Co.. They set a "neutral" rating and a $12.00 price target on the stock. This represents a 12.3% upside from the current price of $10.69.
  • TF Financial (NASDAQ:THRD) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $23.00 price target on the stock. This represents a 77.6% upside from the current price of $12.95.
  • View today's most recent analysts' new coverage at MarketBeat.com right arrow

Upgrade Your Subscription
Manage Your Watchlist
Join Our Facebook Group

Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
 
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
 
© 2006-2024 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.
 
Today's Bonus Content: A new way to collect income from stocks (Click to Opt-in)

No comments:

Post a Comment

[Expiring Soon] How To Simplify Your Strategy And Amplify Your Results

You Can't Afford To Miss This Valuable Information! Hey Trader,  Before we go any further I need to...